Share Price and Basic Stock Data
Last Updated: January 6, 2026, 7:46 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Phyto Chem (India) Ltd operates in the agrochemicals sector, specializing in the production of pesticides. The company’s stock price is currently ₹28.0, with a market capitalization of ₹12.1 Cr. Over the years, Phyto Chem has experienced significant fluctuations in revenue. For instance, sales stood at ₹26.76 Cr in FY 2023, a recovery from ₹23.12 Cr in FY 2022, but projected to decline to ₹14.75 Cr in FY 2024 and further to ₹14.08 Cr in FY 2025. Quarterly sales data also reflects volatility, with sales peaking at ₹12.47 Cr in September 2022 but plummeting to ₹0.64 Cr in June 2023, indicating challenges in maintaining consistent revenue streams. The sales trend showcases a substantial drop in performance, particularly in the recent quarters, which raises concerns about market competitiveness and operational efficiency.
Profitability and Efficiency Metrics
Profitability metrics for Phyto Chem reveal a challenging landscape. The company reported a net profit of ₹-0.68 Cr for the latest period, marking a decline from previous profits. Operating profit margins (OPM) also reflect negative trends, with an OPM of -10.09% reported in the latest quarter, indicative of operational difficulties. The return on equity (ROE) stood at 14.6%, which is relatively low compared to industry standards, suggesting inefficient use of equity capital. Furthermore, the interest coverage ratio (ICR) of 0.61x points to a struggle in covering interest expenses, a critical factor for financial sustainability. The cash conversion cycle (CCC) of 615.87 days indicates inefficiencies in managing working capital, with high inventory and debtor days contributing to this extended cycle.
Balance Sheet Strength and Financial Ratios
Phyto Chem’s balance sheet reveals a precarious financial position, with total borrowings amounting to ₹14.78 Cr against reserves of ₹1.06 Cr, highlighting a significant debt burden relative to its equity base. The debt-to-equity ratio stands at 2.47x, indicating a high level of financial leverage, which poses risks in times of economic downturns. Additionally, the current ratio of 1.26x suggests that the company has just enough short-term assets to cover its short-term liabilities, but this buffer is slim. The return on capital employed (ROCE) of 3.27% is below the industry average, reflecting inefficiencies in utilizing capital to generate profits. The book value per share has decreased to ₹14.85, down from ₹24.68 in FY 2023, indicating a deterioration in shareholder value over the past year.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Phyto Chem indicates a stable promoter holding of 40.40%, which has remained unchanged since December 2022. However, the presence of institutional investors is minimal, with domestic institutional investors (DIIs) holding only 0.19% of the shares. The public holds a significant 54.78%, reflecting a broad base of retail investors. This lack of institutional backing could be a concern for potential investors, as institutional investors often provide stability and credibility to a company’s stock. The number of shareholders has increased to 7,303, which may suggest growing interest among retail investors despite the company’s financial struggles. This trend could signify a speculative interest rather than long-term confidence, raising questions about the sustainability of the current share price.
Outlook, Risks, and Final Insight
Looking ahead, Phyto Chem faces several risks that could impact its performance, including declining sales and profitability. The volatility in revenue and the negative operating profit margin point to potential operational inefficiencies that need addressing. The company’s high debt levels also present a significant risk, particularly in an uncertain economic environment where interest rates may rise. However, the stable promoter holding and increasing retail investor base can provide some support. The company must focus on improving operational efficiency, managing working capital effectively, and exploring avenues for revenue growth to regain investor confidence. A turnaround strategy focusing on cost management and product innovation could be crucial in stabilizing its financial health and enhancing shareholder value in the long run.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 5,035 Cr. | 1,167 | 2,114/1,151 | 12.5 | 487 | 0.51 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 810 Cr. | 240 | 391/165 | 16.6 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 62.0 Cr. | 119 | 149/56.6 | 11.1 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,917 Cr. | 226 | 331/198 | 110 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 1,016 Cr. | 430 | 598/244 | 79.4 | 342 | 0.47 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,200.85 Cr | 1,129.99 | 32.29 | 382.34 | 0.43% | 15.21% | 19.87% | 7.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.47 | 7.88 | 5.00 | 0.64 | 7.21 | 6.51 | 0.45 | 4.61 | 4.37 | 3.65 | 1.46 | 1.50 | 4.36 |
| Expenses | 9.97 | 7.60 | 4.36 | 1.91 | 6.67 | 5.76 | 3.74 | 5.63 | 3.81 | 3.48 | 2.51 | 2.02 | 4.80 |
| Operating Profit | 2.50 | 0.28 | 0.64 | -1.27 | 0.54 | 0.75 | -3.29 | -1.02 | 0.56 | 0.17 | -1.05 | -0.52 | -0.44 |
| OPM % | 20.05% | 3.55% | 12.80% | -198.44% | 7.49% | 11.52% | -731.11% | -22.13% | 12.81% | 4.66% | -71.92% | -34.67% | -10.09% |
| Other Income | 0.03 | 0.06 | 0.07 | 0.15 | 0.01 | 0.07 | 2.09 | 0.01 | 0.01 | 1.94 | 0.51 | 0.40 | 0.31 |
| Interest | 0.46 | 0.48 | 0.66 | 0.56 | 0.63 | 0.44 | 0.42 | 0.38 | 0.38 | 0.52 | 0.57 | 0.33 | 0.35 |
| Depreciation | 0.10 | 0.10 | 0.10 | 0.08 | 0.08 | 0.10 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 |
| Profit before tax | 1.97 | -0.24 | -0.05 | -1.76 | -0.16 | 0.28 | -1.71 | -1.47 | 0.11 | 1.51 | -1.19 | -0.54 | -0.57 |
| Tax % | 0.00% | 29.17% | -360.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.68% | 0.00% | -0.66% | -3.36% | -9.26% | -1.75% |
| Net Profit | 1.98 | -0.31 | 0.12 | -1.76 | -0.16 | 0.29 | -1.71 | -1.47 | 0.11 | 1.52 | -1.16 | -0.48 | -0.56 |
| EPS in Rs | 4.60 | -0.72 | 0.28 | -4.09 | -0.37 | 0.67 | -3.98 | -3.42 | 0.26 | 3.53 | -2.70 | -1.12 | -1.30 |
Last Updated: December 29, 2025, 1:34 pm
Below is a detailed analysis of the quarterly data for Phyto Chem (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 4.36 Cr.. The value appears strong and on an upward trend. It has increased from 1.50 Cr. (Jun 2025) to 4.36 Cr., marking an increase of 2.86 Cr..
- For Expenses, as of Sep 2025, the value is 4.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.02 Cr. (Jun 2025) to 4.80 Cr., marking an increase of 2.78 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.44 Cr.. The value appears strong and on an upward trend. It has increased from -0.52 Cr. (Jun 2025) to -0.44 Cr., marking an increase of 0.08 Cr..
- For OPM %, as of Sep 2025, the value is -10.09%. The value appears strong and on an upward trend. It has increased from -34.67% (Jun 2025) to -10.09%, marking an increase of 24.58%.
- For Other Income, as of Sep 2025, the value is 0.31 Cr.. The value appears to be declining and may need further review. It has decreased from 0.40 Cr. (Jun 2025) to 0.31 Cr., marking a decrease of 0.09 Cr..
- For Interest, as of Sep 2025, the value is 0.35 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.33 Cr. (Jun 2025) to 0.35 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.09 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.57 Cr.. The value appears to be declining and may need further review. It has decreased from -0.54 Cr. (Jun 2025) to -0.57 Cr., marking a decrease of 0.03 Cr..
- For Tax %, as of Sep 2025, the value is -1.75%. The value appears to be increasing, which may not be favorable. It has increased from -9.26% (Jun 2025) to -1.75%, marking an increase of 7.51%.
- For Net Profit, as of Sep 2025, the value is -0.56 Cr.. The value appears to be declining and may need further review. It has decreased from -0.48 Cr. (Jun 2025) to -0.56 Cr., marking a decrease of 0.08 Cr..
- For EPS in Rs, as of Sep 2025, the value is -1.30. The value appears to be declining and may need further review. It has decreased from -1.12 (Jun 2025) to -1.30, marking a decrease of 0.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:48 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.29 | 40.92 | 21.77 | 44.45 | 58.90 | 59.11 | 44.22 | 44.49 | 23.12 | 26.76 | 14.75 | 14.08 | 10.97 |
| Expenses | 26.32 | 38.27 | 20.24 | 41.58 | 56.75 | 56.68 | 42.30 | 42.28 | 21.70 | 24.16 | 18.02 | 15.42 | 12.81 |
| Operating Profit | 2.97 | 2.65 | 1.53 | 2.87 | 2.15 | 2.43 | 1.92 | 2.21 | 1.42 | 2.60 | -3.27 | -1.34 | -1.84 |
| OPM % | 10.14% | 6.48% | 7.03% | 6.46% | 3.65% | 4.11% | 4.34% | 4.97% | 6.14% | 9.72% | -22.17% | -9.52% | -16.77% |
| Other Income | -0.06 | 0.12 | 0.68 | 0.27 | 1.55 | 0.98 | 1.38 | 0.80 | 1.29 | 0.16 | 2.32 | 2.47 | 3.16 |
| Interest | 1.63 | 1.64 | 1.72 | 1.67 | 2.13 | 2.10 | 2.47 | 2.12 | 2.10 | 2.10 | 2.05 | 1.84 | 1.77 |
| Depreciation | 0.35 | 0.32 | 0.31 | 0.31 | 0.36 | 0.40 | 0.41 | 0.43 | 0.41 | 0.40 | 0.34 | 0.34 | 0.34 |
| Profit before tax | 0.93 | 0.81 | 0.18 | 1.16 | 1.21 | 0.91 | 0.42 | 0.46 | 0.20 | 0.26 | -3.34 | -1.05 | -0.79 |
| Tax % | 34.41% | 34.57% | 38.89% | 26.72% | 23.97% | 19.78% | -4.76% | -6.52% | -15.00% | 15.38% | -0.30% | -5.71% | |
| Net Profit | 0.61 | 0.54 | 0.12 | 0.85 | 0.92 | 0.73 | 0.45 | 0.49 | 0.23 | 0.22 | -3.33 | -0.99 | -0.68 |
| EPS in Rs | 1.42 | 1.26 | 0.28 | 1.98 | 2.14 | 1.70 | 1.05 | 1.14 | 0.53 | 0.51 | -7.74 | -2.30 | -1.59 |
| Dividend Payout % | 70.49% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -11.48% | -77.78% | 608.33% | 8.24% | -20.65% | -38.36% | 8.89% | -53.06% | -4.35% | -1613.64% | 70.27% |
| Change in YoY Net Profit Growth (%) | 0.00% | -66.30% | 686.11% | -600.10% | -28.89% | -17.70% | 47.25% | -61.95% | 48.71% | -1609.29% | 1683.91% |
Phyto Chem (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -20% |
| 3 Years: | -15% |
| TTM: | -42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 4% |
| 3 Years: | 15% |
| 1 Year: | -5% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -8% |
| 3 Years: | -16% |
| Last Year: | -14% |
Last Updated: September 5, 2025, 12:30 pm
Balance Sheet
Last Updated: December 4, 2025, 1:49 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
| Reserves | 3.12 | 3.48 | 3.60 | 4.00 | 4.52 | 5.12 | 5.55 | 5.88 | 6.15 | 6.31 | 3.06 | 2.09 | 1.06 |
| Borrowings | 14.22 | 16.00 | 16.04 | 18.46 | 18.55 | 22.08 | 22.98 | 21.37 | 21.23 | 19.47 | 18.19 | 15.77 | 14.78 |
| Other Liabilities | 10.53 | 11.92 | 5.63 | 15.24 | 30.31 | 41.46 | 34.87 | 13.91 | 6.78 | 9.94 | 6.16 | 5.72 | 4.91 |
| Total Liabilities | 32.17 | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 | 25.05 |
| Fixed Assets | 4.21 | 3.68 | 3.50 | 3.25 | 4.10 | 4.18 | 4.67 | 3.43 | 3.13 | 2.75 | 2.74 | 2.39 | 2.23 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.32 | 0.32 | 0.32 | 0.24 | 0.25 | 0.12 | 0.11 | 0.16 | 0.17 | 0.07 | 0.08 | 0.05 | 0.07 |
| Other Assets | 27.64 | 31.70 | 25.75 | 38.51 | 53.24 | 68.21 | 62.92 | 41.87 | 35.16 | 37.20 | 28.89 | 25.44 | 22.75 |
| Total Assets | 32.17 | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 | 25.05 |
Below is a detailed analysis of the balance sheet data for Phyto Chem (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.30 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.30 Cr..
- For Reserves, as of Sep 2025, the value is 1.06 Cr.. The value appears to be declining and may need further review. It has decreased from 2.09 Cr. (Mar 2025) to 1.06 Cr., marking a decrease of 1.03 Cr..
- For Borrowings, as of Sep 2025, the value is 14.78 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 15.77 Cr. (Mar 2025) to 14.78 Cr., marking a decrease of 0.99 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4.91 Cr.. The value appears to be improving (decreasing). It has decreased from 5.72 Cr. (Mar 2025) to 4.91 Cr., marking a decrease of 0.81 Cr..
- For Total Liabilities, as of Sep 2025, the value is 25.05 Cr.. The value appears to be improving (decreasing). It has decreased from 27.88 Cr. (Mar 2025) to 25.05 Cr., marking a decrease of 2.83 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2.23 Cr.. The value appears to be declining and may need further review. It has decreased from 2.39 Cr. (Mar 2025) to 2.23 Cr., marking a decrease of 0.16 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.07 Cr.. The value appears strong and on an upward trend. It has increased from 0.05 Cr. (Mar 2025) to 0.07 Cr., marking an increase of 0.02 Cr..
- For Other Assets, as of Sep 2025, the value is 22.75 Cr.. The value appears to be declining and may need further review. It has decreased from 25.44 Cr. (Mar 2025) to 22.75 Cr., marking a decrease of 2.69 Cr..
- For Total Assets, as of Sep 2025, the value is 25.05 Cr.. The value appears to be declining and may need further review. It has decreased from 27.88 Cr. (Mar 2025) to 25.05 Cr., marking a decrease of 2.83 Cr..
However, the Borrowings (14.78 Cr.) are higher than the Reserves (1.06 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -11.25 | -13.35 | -14.51 | -15.59 | -16.40 | -19.65 | -21.06 | -19.16 | -19.81 | -16.87 | -21.46 | -17.11 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 209.73 | 155.83 | 247.97 | 212.84 | 234.37 | 306.89 | 360.30 | 182.87 | 317.01 | 275.66 | 388.26 | 369.41 |
| Inventory Days | 167.93 | 159.73 | 260.64 | 133.35 | 115.59 | 128.58 | 182.77 | 172.49 | 342.41 | 314.83 | 373.42 | 338.21 |
| Days Payable | 99.24 | 113.43 | 86.08 | 135.72 | 176.25 | 283.01 | 338.07 | 110.32 | 41.10 | 122.87 | 91.09 | 91.75 |
| Cash Conversion Cycle | 278.42 | 202.12 | 422.53 | 210.47 | 173.71 | 152.46 | 205.00 | 245.04 | 618.32 | 467.62 | 670.59 | 615.87 |
| Working Capital Days | 59.32 | 48.26 | 103.95 | 53.62 | 43.75 | 45.14 | 69.58 | 85.08 | 155.35 | 150.45 | 161.34 | 129.88 |
| ROCE % | 13.06% | 12.02% | 7.75% | 11.16% | 12.34% | 10.16% | 8.98% | 6.96% | 7.28% | 7.55% | -4.93% | 3.27% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.31 | -7.75 | 0.52 | 0.53 | 1.15 |
| Diluted EPS (Rs.) | -2.31 | -7.75 | 0.52 | 0.53 | 1.15 |
| Cash EPS (Rs.) | -1.52 | -6.95 | 1.44 | 1.49 | 2.14 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.85 | 17.11 | 24.68 | 24.31 | 23.68 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.85 | 17.11 | 24.68 | 24.31 | 23.68 |
| Revenue From Operations / Share (Rs.) | 32.74 | 34.44 | 62.23 | 53.76 | 103.46 |
| PBDIT / Share (Rs.) | 2.62 | -2.20 | 6.42 | 6.28 | 7.00 |
| PBIT / Share (Rs.) | 1.84 | -3.00 | 5.50 | 5.33 | 6.01 |
| PBT / Share (Rs.) | -2.44 | -7.76 | 0.61 | 0.45 | 1.08 |
| Net Profit / Share (Rs.) | -2.31 | -7.75 | 0.51 | 0.53 | 1.15 |
| PBDIT Margin (%) | 8.01 | -6.39 | 10.31 | 11.68 | 6.76 |
| PBIT Margin (%) | 5.62 | -8.70 | 8.83 | 9.91 | 5.80 |
| PBT Margin (%) | -7.44 | -22.54 | 0.98 | 0.85 | 1.04 |
| Net Profit Margin (%) | -7.04 | -22.48 | 0.83 | 0.99 | 1.10 |
| Return on Networth / Equity (%) | -15.52 | -45.25 | 2.09 | 2.19 | 4.84 |
| Return on Capital Employeed (%) | 9.59 | -12.59 | 16.06 | 16.83 | 17.57 |
| Return On Assets (%) | -3.55 | -10.50 | 0.55 | 0.60 | 1.09 |
| Long Term Debt / Equity (X) | 0.16 | 0.23 | 0.26 | 0.22 | 0.35 |
| Total Debt / Equity (X) | 2.47 | 2.47 | 1.83 | 1.88 | 1.89 |
| Asset Turnover Ratio (%) | 0.47 | 0.41 | 0.68 | 0.55 | 0.78 |
| Current Ratio (X) | 1.26 | 1.31 | 1.44 | 1.40 | 1.35 |
| Quick Ratio (X) | 0.74 | 0.75 | 0.85 | 0.88 | 0.81 |
| Inventory Turnover Ratio (X) | 1.28 | 1.11 | 1.31 | 0.94 | 2.24 |
| Interest Coverage Ratio (X) | 0.61 | -0.46 | 1.31 | 1.29 | 1.42 |
| Interest Coverage Ratio (Post Tax) (X) | 0.46 | -0.62 | 1.11 | 1.11 | 1.23 |
| Enterprise Value (Cr.) | 28.18 | 31.77 | 33.51 | 28.18 | 26.50 |
| EV / Net Operating Revenue (X) | 2.00 | 2.15 | 1.25 | 1.22 | 0.59 |
| EV / EBITDA (X) | 24.97 | -33.54 | 12.14 | 10.43 | 8.81 |
| MarketCap / Net Operating Revenue (X) | 0.88 | 0.92 | 0.52 | 0.37 | 0.16 |
| Price / BV (X) | 1.95 | 1.87 | 1.33 | 0.83 | 0.72 |
| Price / Net Operating Revenue (X) | 0.88 | 0.92 | 0.52 | 0.37 | 0.16 |
| EarningsYield | -0.07 | -0.24 | 0.01 | 0.02 | 0.06 |
After reviewing the key financial ratios for Phyto Chem (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.31. This value is below the healthy minimum of 5. It has increased from -7.75 (Mar 24) to -2.31, marking an increase of 5.44.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.31. This value is below the healthy minimum of 5. It has increased from -7.75 (Mar 24) to -2.31, marking an increase of 5.44.
- For Cash EPS (Rs.), as of Mar 25, the value is -1.52. This value is below the healthy minimum of 3. It has increased from -6.95 (Mar 24) to -1.52, marking an increase of 5.43.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.85. It has decreased from 17.11 (Mar 24) to 14.85, marking a decrease of 2.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.85. It has decreased from 17.11 (Mar 24) to 14.85, marking a decrease of 2.26.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 32.74. It has decreased from 34.44 (Mar 24) to 32.74, marking a decrease of 1.70.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from -2.20 (Mar 24) to 2.62, marking an increase of 4.82.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.84. This value is within the healthy range. It has increased from -3.00 (Mar 24) to 1.84, marking an increase of 4.84.
- For PBT / Share (Rs.), as of Mar 25, the value is -2.44. This value is below the healthy minimum of 0. It has increased from -7.76 (Mar 24) to -2.44, marking an increase of 5.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -2.31. This value is below the healthy minimum of 2. It has increased from -7.75 (Mar 24) to -2.31, marking an increase of 5.44.
- For PBDIT Margin (%), as of Mar 25, the value is 8.01. This value is below the healthy minimum of 10. It has increased from -6.39 (Mar 24) to 8.01, marking an increase of 14.40.
- For PBIT Margin (%), as of Mar 25, the value is 5.62. This value is below the healthy minimum of 10. It has increased from -8.70 (Mar 24) to 5.62, marking an increase of 14.32.
- For PBT Margin (%), as of Mar 25, the value is -7.44. This value is below the healthy minimum of 10. It has increased from -22.54 (Mar 24) to -7.44, marking an increase of 15.10.
- For Net Profit Margin (%), as of Mar 25, the value is -7.04. This value is below the healthy minimum of 5. It has increased from -22.48 (Mar 24) to -7.04, marking an increase of 15.44.
- For Return on Networth / Equity (%), as of Mar 25, the value is -15.52. This value is below the healthy minimum of 15. It has increased from -45.25 (Mar 24) to -15.52, marking an increase of 29.73.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.59. This value is below the healthy minimum of 10. It has increased from -12.59 (Mar 24) to 9.59, marking an increase of 22.18.
- For Return On Assets (%), as of Mar 25, the value is -3.55. This value is below the healthy minimum of 5. It has increased from -10.50 (Mar 24) to -3.55, marking an increase of 6.95.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.23 (Mar 24) to 0.16, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.47. This value exceeds the healthy maximum of 1. There is no change compared to the previous period (Mar 24) which recorded 2.47.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has increased from 0.41 (Mar 24) to 0.47, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.26. This value is below the healthy minimum of 1.5. It has decreased from 1.31 (Mar 24) to 1.26, marking a decrease of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.75 (Mar 24) to 0.74, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.28. This value is below the healthy minimum of 4. It has increased from 1.11 (Mar 24) to 1.28, marking an increase of 0.17.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.61. This value is below the healthy minimum of 3. It has increased from -0.46 (Mar 24) to 0.61, marking an increase of 1.07.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 3. It has increased from -0.62 (Mar 24) to 0.46, marking an increase of 1.08.
- For Enterprise Value (Cr.), as of Mar 25, the value is 28.18. It has decreased from 31.77 (Mar 24) to 28.18, marking a decrease of 3.59.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.00. This value is within the healthy range. It has decreased from 2.15 (Mar 24) to 2.00, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 24.97. This value exceeds the healthy maximum of 15. It has increased from -33.54 (Mar 24) to 24.97, marking an increase of 58.51.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.88, marking a decrease of 0.04.
- For Price / BV (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.87 (Mar 24) to 1.95, marking an increase of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 24) to 0.88, marking a decrease of 0.04.
- For EarningsYield, as of Mar 25, the value is -0.07. This value is below the healthy minimum of 5. It has increased from -0.24 (Mar 24) to -0.07, marking an increase of 0.17.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Phyto Chem (India) Ltd:
- Net Profit Margin: -7.04%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.59% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -15.52% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.74
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 32.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.47
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.04%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | Survey No.628, Temple Street, Sangareddy Dist. Telangana 502313 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. P Sreemannarayana | Chairman |
| Mr. Y Nayudamma | Managing Director |
| Mr. Y Janaki Ramaiah | Executive Director |
| Mr. S Y Sampath Kumar | Independent Director |
| Dr. M Sreerama Murthy | Independent Director |
| Mrs. G Vijitha | Independent Director |
| Mr. N Nagendra Naidu | Independent Director |
| Mr. N Sudhaka | Addnl.Non Exe.Independent Director |
| Mr. Y Sreemannarayana | Addnl.Non Exe.Independent Director |
| Mr. K Srinivasa Rao | Additional Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Phyto Chem (India) Ltd?
Phyto Chem (India) Ltd's intrinsic value (as of 06 January 2026) is ₹22.34 which is 20.21% lower the current market price of ₹28.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹12.1 Cr. market cap, FY2025-2026 high/low of ₹39.9/24.5, reserves of ₹1.06 Cr, and liabilities of ₹25.05 Cr.
What is the Market Cap of Phyto Chem (India) Ltd?
The Market Cap of Phyto Chem (India) Ltd is 12.1 Cr..
What is the current Stock Price of Phyto Chem (India) Ltd as on 06 January 2026?
The current stock price of Phyto Chem (India) Ltd as on 06 January 2026 is ₹28.0.
What is the High / Low of Phyto Chem (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Phyto Chem (India) Ltd stocks is ₹39.9/24.5.
What is the Stock P/E of Phyto Chem (India) Ltd?
The Stock P/E of Phyto Chem (India) Ltd is .
What is the Book Value of Phyto Chem (India) Ltd?
The Book Value of Phyto Chem (India) Ltd is 12.5.
What is the Dividend Yield of Phyto Chem (India) Ltd?
The Dividend Yield of Phyto Chem (India) Ltd is 0.00 %.
What is the ROCE of Phyto Chem (India) Ltd?
The ROCE of Phyto Chem (India) Ltd is 3.27 %.
What is the ROE of Phyto Chem (India) Ltd?
The ROE of Phyto Chem (India) Ltd is 14.6 %.
What is the Face Value of Phyto Chem (India) Ltd?
The Face Value of Phyto Chem (India) Ltd is 10.0.